2.3. Chemotherapy Administration
ADVERSE EVENTS
Oxaliplatin was given as a single intravenous infusion in combination with oral capecitabine twice a day for fourteen days (CAPOX). Paclitaxel (intravenous infusion) was given in combination with carboplatin (intravenous infusion). Both regimens were administered on a thrice-weekly schedule. Chemotherapy dose, dose reductions, and adverse events were registered and prescribed by an oncologist not involved in this study.